Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	New Amedeo service: Amedeo COVID-19 (formerly 2019-nCoV) Weekly publication summary

Neoplasms of the CNS

Free Subscription Articles published in Am J Clin Oncol Retrieve available abstracts of 27 articles: HTML format Text format

Single Articles

September 2019
1. GUO X, Zhang M, Li Q, Zhao J, et al
   Evaluation of Genetic Variants in MIR3142HG in Susceptibility to and Prognosis of Glioma.
   Am J Clin Oncol. 2019 Sep 10. doi: 10.1097/COC.0000000000000587.
   PubMed     Text format     Abstract available
   
   
   August 2019
2. JOHNSTON SK, Whitmire P, Massey SC, Kumthekar P, et al
   ENvironmental Dynamics Underlying Responsive Extreme Survivors (ENDURES) of Glioblastoma: A Multidisciplinary Team-based, Multifactorial Analytical Approach.
   Am J Clin Oncol. 2019;42:655-661.
   PubMed     Text format     Abstract available
   
   
   April 2019
3. PALMER JD, Bhamidipati D, Shukla G, Sharma D, et al
   Rapid Early Tumor Progression is Prognostic in Glioblastoma Patients.
   Am J Clin Oncol. 2019 Apr 9. doi: 10.1097/COC.0000000000000537.
   PubMed     Text format     Abstract available
   
   
   March 2019
4. RYCKMAN JM, Surkar SM, Haque W, Butler EB, et al
   Sequencing of Chemotherapy and Radiotherapy for Newly Diagnosed Anaplastic Oligodendroglioma and Oligoastrocytoma.
   Am J Clin Oncol. 2019;42:258-264.
   PubMed     Text format     Abstract available
   
   
   
5. MURPHY B, Walker J, Bassale S, Monaco D, et al
   Concurrent Radiosurgery and Immune Checkpoint Inhibition: Improving Regional Intracranial Control for Patients With Metastatic Melanoma.
   Am J Clin Oncol. 2019;42:253-257.
   PubMed     Text format     Abstract available
   
   
   February 2019
6. RYCKMAN JM, Appiah AK, Lyden E, Verma V, et al
   Concurrent Versus Sequential Chemoradiation for Low-grade Gliomas Meeting RTOG 9802 Criteria.
   Am J Clin Oncol. 2019 Feb 12. doi: 10.1097/COC.0000000000000519.
   PubMed     Text format     Abstract available
   
   
   
7. BATISTA RL, Musolino NRC, Cescato VAS, da Silva GO, et al
   Cabergoline in the Management of Residual Nonfunctioning Pituitary Adenoma: A Single-Center, Open-Label, 2-Year Randomized Clinical Trial.
   Am J Clin Oncol. 2019;42:221-227.
   PubMed     Text format     Abstract available
   
   
   November 2018
8. PHILTEOS J, Karmur BS, Mansouri A
   MGMT Testing in Glioblastomas: Pitfalls and Opportunities.
   Am J Clin Oncol. 2018 Nov 15. doi: 10.1097/COC.0000000000000490.
   PubMed     Text format     Abstract available
   
   
   June 2018
9. LEONE JP, Haraldsson B, Mott SL, McDowell BD, et al
   Treatment Patterns and Survival of Elderly Patients With Breast Cancer Brain Metastases.
   Am J Clin Oncol. 2018 Jun 30. doi: 10.1097/COC.0000000000000477.
   PubMed     Text format     Abstract available
   
   
   
10. SUTERA P, Kalash R, Flickinger J, Engh J, et al
    Clinical and Molecular Recursive Partitioning Analysis of High-grade Glioma Treated With IMRT.
    Am J Clin Oncol. 2018 Jun 14. doi: 10.1097/COC.0000000000000470.
    PubMed     Text format     Abstract available
    
    
    May 2018
11. PASQUALETTI F, Pace A, Gonnelli A, Villani V, et al
    Single-agent Bevacizumab in Recurrent Glioblastoma After Second-line Chemotherapy With Fotemustine: The Experience of the Italian Association of Neuro-Oncology.
    Am J Clin Oncol. 2018 May 18. doi: 10.1097/COC.0000000000000464.
    PubMed     Text format     Abstract available
    
    
    
12. ZAVITSANOS PJ, Wazer DE, Hepel JT, Wang Y, et al
    BRCA1 Mutations Associated With Increased Risk of Brain Metastases in Breast Cancer: A 1: 2 Matched-pair Analysis.
    Am J Clin Oncol. 2018 May 18. doi: 10.1097/COC.0000000000000466.
    PubMed     Text format     Abstract available
    
    
    
13. LOMBARDI G, Bergo E, Del Bianco P, Bellu L, et al
    Quality of Life Perception, Cognitive Function, and Psychological Status in a Real-world Population of Glioblastoma Patients Treated With Radiotherapy and Temozolomide: A Single-center Prospective Study.
    Am J Clin Oncol. 2018 May 10. doi: 10.1097/COC.0000000000000459.
    PubMed     Text format     Abstract available
    
    
    April 2018
14. RYDZEWSKI NR, Khan AJ, Strauss JB, Chmura SJ, et al
    Mortality After Stereotactic Radiosurgery for Brain Metastases and Implications for Optimal Utilization: A National Cancer Database Study.
    Am J Clin Oncol. 2018 Apr 10. doi: 10.1097/COC.0000000000000441.
    PubMed     Text format     Abstract available
    
    
    March 2018
15. TIMMONS JJ, Zhang K, Fong J, Lok E, et al
    Literature Review of Spinal Cord Glioblastoma.
    Am J Clin Oncol. 2018 Mar 9. doi: 10.1097/COC.0000000000000434.
    PubMed     Text format     Abstract available
    
    
    February 2018
16. HAQUE W, Verma V, Butler EB, Teh BS, et al
    Patterns of Care and Outcomes of Hypofractionated Chemoradiation Versus Conventionally Fractionated Chemoradiation for Glioblastoma in the Elderly Population.
    Am J Clin Oncol. 2018;41:167-172.
    PubMed     Text format     Abstract available
    
    
    October 2017
17. MOKHTECH M, Morris CG, Indelicato DJ, Rutenberg MS, et al
    Patterns of Failure in Patients With Adult Medulloblastoma Presenting Without Extraneural Metastasis.
    Am J Clin Oncol. 2017 Oct 17. doi: 10.1097/COC.0000000000000407.
    PubMed     Text format     Abstract available
    
    
    
18. BATES JE, Youn P, Peterson CR 3rd, Usuki KY, et al
    Radiotherapy for Brain Metastases From Renal Cell Carcinoma in the Targeted Therapy Era: The University of Rochester Experience.
    Am J Clin Oncol. 2017;40:439-443.
    PubMed     Text format     Abstract available
    
    
    September 2017
19. REZNIK E, Smith AW, Taube S, Mann J, et al
    Radiation and Immunotherapy in High-grade Gliomas: Where Do We Stand?
    Am J Clin Oncol. 2017 Sep 12. doi: 10.1097/COC.0000000000000406.
    PubMed     Text format     Abstract available
    
    
    August 2017
20. BURRI SH, Gondi V, Brown PD, Mehta MP, et al
    The Evolving Role of Tumor Treating Fields in Managing Glioblastoma: Guide for Oncologists.
    Am J Clin Oncol. 2017 Aug 24. doi: 10.1097/COC.0000000000000395.
    PubMed     Text format     Abstract available
    
    
    June 2017
21. ELLSWORTH S, Ye X, Grossman SA
    Clinical, Radiographic, and Pathologic Findings in Patients Undergoing Reoperation Following Radiation Therapy and Temozolomide for Newly Diagnosed Glioblastoma.
    Am J Clin Oncol. 2017;40:219-222.
    PubMed     Text format     Abstract available
    
    
    
22. BOXERMAN JL, Ellingson BM, Jeyapalan S, Elinzano H, et al
    Longitudinal DSC-MRI for Distinguishing Tumor Recurrence From Pseudoprogression in Patients With a High-grade Glioma.
    Am J Clin Oncol. 2017;40:228-234.
    PubMed     Text format     Abstract available
    
    
    
23. GHOSE A, Guha G, Kundu R, Tew J, et al
    CNS Hemangiopericytoma: A Systematic Review of 523 Patients.
    Am J Clin Oncol. 2017;40:223-227.
    PubMed     Text format     Abstract available
    
    
    March 2017
24. MCTYRE E, Lucas JT, Helis C, Farris M, et al
    Outcomes for Anaplastic Glioma Treated With Radiation Therapy With or Without Concurrent Temozolomide.
    Am J Clin Oncol. 2017 Mar 15. doi: 10.1097/COC.0000000000000380.
    PubMed     Text format     Abstract available
    
    
    
25. ZHANG C, Verma V, Lyden ER, Horowitz DP, et al
    The Role of Definitive Radiotherapy in Craniopharyngioma: A SEER Analysis.
    Am J Clin Oncol. 2017 Mar 3. doi: 10.1097/COC.0000000000000378.
    PubMed     Text format     Abstract available
    
    
    February 2017
26. MILANO MT, Grossman CE
    Meningioma in Breast Cancer Patients: Population-based Analysis of Clinicopathologic Characteristics.
    Am J Clin Oncol. 2017;40:11-16.
    PubMed     Text format     Abstract available
    
    
    September 2016
27. MOOTS PL, O'Neill A, Londer H, Mehta M, et al
    Preradiation Chemotherapy for Adult High-risk Medulloblastoma: A Trial of the ECOG-ACRIN Cancer Research Group (E4397).
    Am J Clin Oncol. 2016.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: